LAVAL, Quebec, March 24, 2011 (GLOBE NEWSWIRE) -- Neptune Technologies & Bioressources Inc. (“Neptune”) (Nasdaq:NEPT) (TSX-V:NTB) and its subsidiary Acasti Pharma Inc. (“Acasti”) are pleased to announce the presentations of clinical and recent preclinical results on the 24 and 25 March, 2011, respectively, at the Joint Conference - Nutrition, Physical Activity and Metabolism / Cardiovascular Disease Epidemiology and Prevention 2011 Scientific Sessions of the American Heart Association held in Atlanta, GA, USA.
